Zylox-Tonbridge Medical Technology Co (FRA:818) EV-to-EBITDA : -21.75 (As of Jun. 23, 2024)

Zylox-Tonbridge Medical Technology Co EV-to-EBITDA Chart

Zylox-Tonbridge Medical Technology Co Semi-Annual Data
	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
EV-to-EBITDA	Get a 7-Day Free Trial				-20.74	-	-22.52	-	-53.61

Competitive Comparison of Zylox-Tonbridge Medical Technology Co's EV-to-EBITDA

For the Medical Devices subindustry, Zylox-Tonbridge Medical Technology Co's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Zylox-Tonbridge Medical Technology Co's EV-to-EBITDA Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Zylox-Tonbridge Medical Technology Co's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Zylox-Tonbridge Medical Technology Co's EV-to-EBITDA falls into.

Zylox-Tonbridge Medical Technology Co EV-to-EBITDA Calculation

Zylox-Tonbridge Medical Technology Co's EV-to-EBITDA for today is calculated as:

Zylox-Tonbridge Medical Technology Co's current Enterprise Value is €214.81 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Zylox-Tonbridge Medical Technology Co's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was €-9.88 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Zylox-Tonbridge Medical Technology Co  (FRA:818) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Zylox-Tonbridge Medical Technology Co's PE Ratio for today is calculated as:

Zylox-Tonbridge Medical Technology Co's share price for today is €1.17.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Zylox-Tonbridge Medical Technology Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was €-0.031.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?

Zylox-Tonbridge Medical Technology Co EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Zylox-Tonbridge Medical Technology Co's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

Zylox-Tonbridge Medical Technology Co (FRA:818) Business Description